Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$59.06 - $72.15 $516,302 - $630,735
-8,742 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$62.09 - $86.14 $542,790 - $753,035
8,742 New
8,742 $562,000
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $2.04 Million - $2.56 Million
-47,586 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$40.53 - $50.7 $837,390 - $1.05 Million
20,661 Added 76.74%
47,586 $1.98 Million
Q1 2018

May 08, 2018

BUY
$44.08 - $55.05 $1.19 Million - $1.48 Million
26,925 New
26,925 $1.19 Million
Q4 2017

Feb 13, 2018

SELL
$50.3 - $64.39 $661,495 - $846,792
-13,151 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$45.56 - $59.57 $599,159 - $783,405
13,151
13,151 $667,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.